~~<i id='CF3DBD4624'><strike id='CF3DBD4624'><tt id='CF3DBD4624'><pre id='CF3DBD4624'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：leisure time 2025-10-02 21:36:44 - browse：93371

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Idaho college killings prosecutors challenge defense's grand jury claims

leisure time

Wikipedia

focus

hotspot

LISELOTTESABROE/Scanpix/AFPviaGettyImagesThereleaseofNovoNordisk’slatestearningsreportonThursdayprov

WSS

What to do when lifesaving products contribute to climate change

Novo Nordisk touts Wegovy study, but still struggling with supply

30 years of 'Listening to Prozac'

Senators push IRS to launch nonprofit hospital probe

What to do when lifesaving products contribute to climate change

Illumina slashes 2023 revenue projections yet again

focus

hotspot

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Be careful with at

Jerome Adams on the need for new antivirals for Covid

Treatments for cramps don't cut it. Why aren't there better options?

At least 13 dead in Texas as scorching temps continue

What don’t we know about an Alzheimer’s drug side effect?

How one medical school became remarkably diverse

Mark Cuban is blaming the wrong people for high drug costs

Tori Bowie and the unacceptable rates of Black maternal death

Megan Rapinoe shares emotional post following US Women's World Cup exit

leisure time

BMS, looking to build heart drug business, turns to AI for diagnosis

With clinical trial data readouts, here's how to spot spin

As biotech industry slumps, bioscience job market is upside down

30 years of 'Listening to Prozac'

Will the market for weight loss drugs really reach $100 billion?

Illumina slashes 2023 revenue projections yet again

Wikipedia

focus

hotspot

hotspot